<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://kenyamazaki.com/2026/09/08/egenesis/</loc><news:news><news:publication><news:name>Ken リクルターブログ</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-09-07T20:00:00+00:00</news:publication_date><news:title>豚の腎臓を移植で透析なしで271日過ごした</news:title><news:keywords>eGenesis, Tim Andrews, Biotechnology, xenotransplantation, pig-to-human organ transplant, kidney xenograft, gene-edited pig kidney, immunosuppression, The Lancet, end-stage kidney disease, transplant rejection, Harvard Medical School, porcine organ, regenerative medicine, organ shortage, Massachusetts General Hospital, UKidney, transplant medicine, Mike Curtis, xenograft survival, United Therapeutics, FDA clinical trial, Japan healthcare implications</news:keywords></news:news><image:image><image:loc>https://kenyamazaki.com/wp-content/uploads/2026/09/pexels-photo-8939934.jpeg?w=100</image:loc></image:image></url></urlset>
